Evaluation of Depression and Anxiety Levels of Parents of Children with Spina Bifida

Studies in the literature have measured the anxiety and depression levels of parents of children with spina bifida. Additionally, it has been reported that parents of children with non-neurogenic lower urinary tract dysfunction, such as nocturnal enuresis and overactive bladder, have increased levels of anxiety and depression. In this study, the investigators aim to evaluate, for the first time, the effect of urinary system symptoms and findings in children with spina bifida on the anxiety and depression levels of their parents.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Spina Bifida Anxiety Disorders Behavior Behavioral Symptoms Congenital Abnormalities Congenital, Hereditary, and Neonatal Diseases and Abnormalities Depression Mental Disorders Nervous System Diseases Nervous System Malformations Neural Tube Defects Spinal Dysraphism

Sex eligibility

All sexes

Study type

Observational

Primary location

Marmara University School of Medicine Urology Department

Istanbul, 34854, Turkey (Türkiye)

About this study

Between January 2024 and December 2024, the demographic data of patients with spina bifida under follow-up, as well as the results of dimercaptosuccinic acid (DMSA) static renal scintigraphy, urinary ultrasonography (USG), and voiding cystourethrography (VCUG), which indicate upper urinary tract (UUT) damage, were recorded. Symptom scoring was performed on the primary caregiver of the child, and anxiety and depression scores were calculated. The Hospital Anxiety and Depression Scale (HADS) and the Beck Anxiety Inventory were used to assess these symptoms in the parents. The presence of renal scarring, hydronephrosis, or vesicoureteral reflux (VUR) in the DMSA was considered as UUT damage. Patients were divided into subgroups based on demographic data, UUT damage, history of febrile urinary tract infections (UTIs), incontinence, and the presence of motor deficits. These groups were then compared in terms of anxiety and depression scores.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Having a child with spina bifida

Exclusion criteria

Diagnosis of psychiatric illness

Treatment and study plan

Anxiety, Depression levels

Diagnostic Test

Parents of children with spina bifida will be filled out symptom scores regarding depression and anxiety levels.

Primary outcomes

Anxiety Level- Hospital Anxiety Scale

Time frame: Baseline

For Anxiety Hospital Anxiety scale used

In the Hospital Anxiety Score, the minimum score is 0, and the maximum score is 21. As the score increases, it indicates higher levels of anxiety.
Depression Level

Time frame: Baseline

For Depression Hospital Depression scale used

In the Hospital Depression Score, the minimum score is 0, and the maximum score is 21. As the score increases, it indicates higher levels of depression.
Anxiety Level- BECK Scale

Time frame: Baseline

In the BECK Scale, the minimum score is 0, and the maximum score is 63. As the score increases, it indicates higher levels of pain.

Sponsors and collaborators

Lead sponsor

Marmara University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Jan 31, 2025
Registry last updated: Jan 31, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting